Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,666
archived clinical trials in
Hospital

A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Atlanta, GA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Chicago, IL
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Kansas City, KA
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated:  12/30/2015
Clinical Research Facility
mi
from
Detroit, MI
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Multiple-Dose Efficacy and Safety Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
Status: Enrolling
Updated: 12/30/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Center for NeuroSkills
mi
from
Bakersfield, CA
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Center for NeuroSkills
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Baylor University Medical Center
mi
from
Dallas, TX
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated:  12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated: 12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated:  12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated: 12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated:  12/31/2015
Walter Reed National Military Medical Center (WRNMMC)
mi
from
Bethesda, MD
Musculotendinous Tissue Repair Unit and Reinforcement (MTURR)
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury
Status: Enrolling
Updated: 12/31/2015
Walter Reed National Military Medical Center (WRNMMC)
mi
from
Bethesda, MD
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Miami and Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Duke University
mi
from
Durham, NC
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Cincinnati
mi
from
Cincinnati, OH
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Ohio State University
mi
from
Columbus, OH
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Temple University
mi
from
Philadelphia, PA
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated:  12/31/2015
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)
Phase 2, Randomized Clinical Trial of the Safety and Efficacy of Brain Tissue Oxygen Monitoring in the Management of Severe Traumatic Brain Injury.
Status: Enrolling
Updated: 12/31/2015
University of Washington; Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
Status: Enrolling
Updated:  12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
A Phase I/II Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
Status: Enrolling
Updated: 12/31/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury (Coordinating Center Protocol)
Status: Enrolling
Updated:  1/2/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) Coordinating Center
Musculotendinous Tissue Unit Repair and Reinforcement (MTURR) With the Use of Biologic Scaffolds for Patients Suffering From Severe Skeletal Muscle Injury (Coordinating Center Protocol)
Status: Enrolling
Updated: 1/2/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Valproate for Mood Swings and Alcohol Use Following Head Injury
A Double Blind Trial of Divalproex Sodium for Affective Lability and Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated:  1/4/2016
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Valproate for Mood Swings and Alcohol Use Following Head Injury
A Double Blind Trial of Divalproex Sodium for Affective Lability and Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated: 1/4/2016
Denver Veterans Affairs Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
Status: Enrolling
Updated:  1/4/2016
Jewish Hospital
mi
from
Cincinnati, OH
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
Does Detailed Informed Consent for Cardiopulmonary Resuscitation and Mechanical Ventilation Impact Patients' Decisions and Outcomes?
Status: Enrolling
Updated: 1/4/2016
Jewish Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Pasadena, MD
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Pasadena, MD
Click here to add this to my saved trials
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
Austin, TX
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated:  1/4/2016
Clinical Research Facility
mi
from
San Antonio, TX
Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
A Phase 3, Randomized, Double-Blind, Multiple-Dose, Parallel-Group, Placebo-Controlled Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain
Status: Enrolling
Updated: 1/4/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Comparison of Inhalation vs. Intravenous Induction
A Comparison of the Effect on Temperature Between Patients Induced With Intravenous Propofol vs Inhalation Induction With Sevoflurane
Status: Enrolling
Updated:  1/4/2016
Albert EinsteinMedical Center
mi
from
Philadelphia, PA
A Comparison of Inhalation vs. Intravenous Induction
A Comparison of the Effect on Temperature Between Patients Induced With Intravenous Propofol vs Inhalation Induction With Sevoflurane
Status: Enrolling
Updated: 1/4/2016
Albert EinsteinMedical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
Lithium Augmentation for Hyperarousal Symptoms of Traumatic Stress Disorder: Pilot Study
Status: Enrolling
Updated:  1/5/2016
Denver Veterans Hospital
mi
from
Denver, CO
Lithium Augmentation for Hyperarousal Symptoms of Post Traumatic Stress Disorder: Pilot Study
Lithium Augmentation for Hyperarousal Symptoms of Traumatic Stress Disorder: Pilot Study
Status: Enrolling
Updated: 1/5/2016
Denver Veterans Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
St. Vincent's Hospital
mi
from
Birmingham, AL
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
St. Vincent's Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
University of Colorado
mi
from
Aurora, CO
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Massachusetts General Hospital
mi
from
Boston, MA
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
The Mayo Clinic
mi
from
Rochester, MN
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Gaston Memorial Hospital
mi
from
Gastonia, NC
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Gaston Memorial Hospital
mi
from
Gastonia, NC
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Cleveland Clinic
mi
from
Cleveland, OH
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Methodist Hospital
mi
from
Houston, TX
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated:  1/5/2016
Texas Heart Institute
mi
from
Houston, TX
Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement
KALAHARI-1: Kallikrein Antagonist (DX-88 [Ecallantide]) Effect on Blood Loss Associated With Heart Surgery Requiring Institution of Bypass
Status: Enrolling
Updated: 1/5/2016
Texas Heart Institute
mi
from
Houston, TX
Click here to add this to my saved trials
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated:  1/7/2016
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated: 1/7/2016
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Click here to add this to my saved trials
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated:  1/7/2016
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated: 1/7/2016
James A. Haley Veterans' Hospital, Tampa, FL
mi
from
Tampa, FL
Click here to add this to my saved trials
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated:  1/7/2016
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated: 1/7/2016
Michael E. DeBakey VA Medical Center (152)
mi
from
Houston, TX
Click here to add this to my saved trials
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated:  1/7/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
SCI-VIP: Predictive Outcome Model Over Time for Employment (PrOMOTE)
Predictive Outcome Model Over Time for Employment (PROMOTE)
Status: Enrolling
Updated: 1/7/2016
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
mi
from
Boston, MA
Click here to add this to my saved trials